49.79
前日終値:
$50.36
開ける:
$50.5
24時間の取引高:
762.96K
Relative Volume:
0.80
時価総額:
$1.36B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.92%
1か月 パフォーマンス:
-11.34%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Hinge Health Inc Stock (HNGE) Company Profile
HNGE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HNGE
Hinge Health Inc
|
49.79 | 3.95B | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
![]()
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-09-05 | 開始されました | Robert W. Baird | Neutral |
2025-07-14 | 開始されました | Citizens JMP | Mkt Outperform |
2025-06-16 | 開始されました | Barclays | Overweight |
2025-06-16 | 開始されました | BofA Securities | Buy |
2025-06-16 | 開始されました | Canaccord Genuity | Buy |
2025-06-16 | 開始されました | Evercore ISI | Outperform |
2025-06-16 | 開始されました | KeyBanc Capital Markets | Overweight |
2025-06-16 | 開始されました | Morgan Stanley | Overweight |
2025-06-16 | 開始されました | Needham | Buy |
2025-06-16 | 開始されました | Piper Sandler | Overweight |
2025-06-16 | 開始されました | RBC Capital Mkts | Outperform |
2025-06-16 | 開始されました | Raymond James | Outperform |
2025-06-16 | 開始されました | Stifel | Buy |
2025-06-16 | 開始されました | Truist | Buy |
2025-06-16 | 開始されました | William Blair | Outperform |
すべてを表示
Hinge Health Inc (HNGE) 最新ニュース
Will Hinge Health Inc. Class stock outperform benchmarksMarket Risk Analysis & Low Volatility Stock Suggestions - newser.com
Can Hinge Health Inc. Class stock deliver consistent EPS growthWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
What insider purchases suggest about Hinge Health Inc. Class stockTrade Analysis Summary & Short-Term High Return Strategies - newser.com
Will Hinge Health Inc. Class stock attract long term capital inflowsMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com
Hinge Health (NYSE:HNGE) Given Sell (D) Rating at Weiss Ratings - MarketBeat
Can Hinge Health Inc. Class stock ride next bull market cycleEarnings Recap Report & Verified Chart Pattern Trade Signals - newser.com
Hinge Health Shares Surge Amid Analyst Optimism - TipRanks
Hinge Health, Inc. Class A Common Stock (NYSE:HNGE) Stock Quote | FinancialContent - FinancialContent
Hinge Health (HNGE): Evaluating Valuation After Recent Share Price Momentum and Growth Outlook Shift - Yahoo Finance
Will Hinge Health Inc. Class stock rise with strong economy2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
Hinge Health: Experiencing Both Growth And Significant Risks, Hold Ahead Of Q3 Earnings - Seeking Alpha
Hinge Health IPO Date, Price, Terms, and Performance - Access IPOs
CHURCHILL MANAGEMENT Corp Takes Position in Hinge Health Inc. $HNGE - MarketBeat
How Hinge Health Inc. Class stock trades after rate cutsBuy Signal & Daily Chart Pattern Signals - newser.com
Assessing Hinge Health (HNGE) Valuation After Recent Share Price Gains and New Partnerships - Sahm
Jim Cramer Says if Hinge Health Comes Down a Little More He “Would Buy More” - MSN
Hinge Health to announce third quarter 2025 financial results on November 4, 2025 - The Joplin Globe
Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential - TipRanks
Hinge Health Jumps 17% After Top-Priced $437 Million IPO - MSN
Trump Administration Review Targets Medical Supply ChainBecton Dickinson (NYSE:BDX), Baxter Intl (NYSE:BAX) - Benzinga
Hinge Health (NYSE:HNGE) Shares Down 6.3%Here's What Happened - MarketBeat
Hinge Health Inc. (NYSE:HNGE) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
AI Helps Hinge Health Get Closer To Profit Margins Goal - Finimize
Hinge Health Likely to Hit 85% Gross Margin by 2027, Morgan Stanley Says - MarketScreener
Morgan Stanley Raises Price Target on Hinge Health to $67 From $57, Keeps Overweight Rating - MarketScreener
Stifel Raises Hinge Health (HNGE) PT to $66 on Strong Business Momentum, Product Innovation - Insider Monkey
Hinge Health IPO attracts more orders for shares than available: report - MSN
Hinge Health Inc (HNGE) 財務データ
Hinge Health Inc (HNGE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Hinge Health Inc (HNGE) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Bessemer Venture Partners X L. | 10% Owner |
May 23 '25 |
Sale |
32.00 |
725,066 |
23,202,112 |
0 |
Atomico Advisors IV, Ltd. | 10% Owner |
May 23 '25 |
Sale |
32.00 |
2,651,103 |
84,835,296 |
0 |
Insight Holdings Group, LLC | 10% Owner |
May 23 '25 |
Sale |
32.00 |
1,250,000 |
40,000,000 |
0 |
11.2 Capital I Partners, LLC | 10% Owner |
May 23 '25 |
Sale |
32.00 |
1,396,340 |
44,682,880 |
0 |
大文字化:
|
ボリューム (24 時間):